FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Nussbaum Robert L 2. Issuer Name and Ticker or Trading Symbol Invitae Corp [ NVTA ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Medical Officer
(Last)         (First)         (Middle)
C/O INVITAE CORPORATION, 1400 16TH STREET
3. Date of Earliest Transaction (MM/DD/YYYY)
4/30/2021
(Street)
SAN FRANCISCO, CA 94103
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  4/30/2021    A    44700 (1) A $0.00  276789 (2) D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)  $34.90  4/30/2021    A     23200       (3) 4/30/2031  Common Stock  23200  $0.00  23200  D   

Explanation of Responses:
(1)  Shares issuable upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3rd of the total award vesting on each of May 15, 2022, 2023 and 2024.
(2)  Includes an aggregate of 145,517 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
(3)  Option vests over four years, with 25% of the shares vesting on April 30, 2021, and 1/48th of the remaining shares vesting monthly thereafter for the remaining three years.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nussbaum Robert L
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO, CA 94103


Chief Medical Officer

Signatures
/s/ Thomas R. Brida, Attorney-in-Fact 5/4/2021
**Signature of Reporting Person Date
Invitae (NYSE:NVTA)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Invitae Charts.
Invitae (NYSE:NVTA)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Invitae Charts.